NCT03125603View on ClinicalTrials.gov

Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 13, 2017

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Carcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse Reactions
Interventions
OTHER

Consultation of the patient's medical files at the hospital

Gradation of the adverse events according to CTCAE scale 4.03 (June 2010).

Trial Locations (1)

1200

Cliniques Universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT03125603 - Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer | Biotech Hunter | Biotech Hunter